Overactive Bladder Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: ODA3BC0E2F25EN
Market Monitor Global

Abstracts

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).

This report contains market size and forecasts of Overactive Bladder Therapeutics in Global, including the following market information:

Global Overactive Bladder Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Overactive Bladder Therapeutics market was valued at 5247.6 million in 2021 and is projected to reach US$ 6372.6 million by 2028, at a CAGR of 2.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anticholinergics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Overactive Bladder Therapeutics include Astellas Pharma, Allergan, Pfizer, Johnson & Johnson and Teva (Activas), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Overactive Bladder Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Overactive Bladder Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Overactive Bladder Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Anticholinergics
• Mirabegron
• Botox

Global Overactive Bladder Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Overactive Bladder Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Idiopathic Overactive Bladder
• Neurogenic Overactive Bladder

Global Overactive Bladder Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Overactive Bladder Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Overactive Bladder Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Overactive Bladder Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Astellas Pharma
• Allergan
• Pfizer
• Johnson & Johnson
• Teva (Activas)

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Overactive Bladder Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Overactive Bladder Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OVERACTIVE BLADDER THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Overactive Bladder Therapeutics Market Size: 2021 VS 2028
2.2 Global Overactive Bladder Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Overactive Bladder Therapeutics Players in Global Market
3.2 Top Global Overactive Bladder Therapeutics Companies Ranked by Revenue
3.3 Global Overactive Bladder Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Overactive Bladder Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Overactive Bladder Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Overactive Bladder Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Overactive Bladder Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Overactive Bladder Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Overactive Bladder Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Anticholinergics
  4.1.3 Mirabegron
  4.1.4 Botox
4.2 By Type - Global Overactive Bladder Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Overactive Bladder Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Overactive Bladder Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Overactive Bladder Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Overactive Bladder Therapeutics Market Size, 2021 & 2028
  5.1.2 Idiopathic Overactive Bladder
  5.1.3 Neurogenic Overactive Bladder
5.2 By Application - Global Overactive Bladder Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Overactive Bladder Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Overactive Bladder Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Overactive Bladder Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Overactive Bladder Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Overactive Bladder Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Overactive Bladder Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Overactive Bladder Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Overactive Bladder Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Overactive Bladder Therapeutics Revenue, 2017-2028
  6.3.2 US Overactive Bladder Therapeutics Market Size, 2017-2028
  6.3.3 Canada Overactive Bladder Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Overactive Bladder Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Overactive Bladder Therapeutics Revenue, 2017-2028
  6.4.2 Germany Overactive Bladder Therapeutics Market Size, 2017-2028
  6.4.3 France Overactive Bladder Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Overactive Bladder Therapeutics Market Size, 2017-2028
  6.4.5 Italy Overactive Bladder Therapeutics Market Size, 2017-2028
  6.4.6 Russia Overactive Bladder Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Overactive Bladder Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Overactive Bladder Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Overactive Bladder Therapeutics Revenue, 2017-2028
  6.5.2 China Overactive Bladder Therapeutics Market Size, 2017-2028
  6.5.3 Japan Overactive Bladder Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Overactive Bladder Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Overactive Bladder Therapeutics Market Size, 2017-2028
  6.5.6 India Overactive Bladder Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Overactive Bladder Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Overactive Bladder Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Overactive Bladder Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Overactive Bladder Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Overactive Bladder Therapeutics Market Size, 2017-2028
  6.7.3 Israel Overactive Bladder Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Overactive Bladder Therapeutics Market Size, 2017-2028
  6.7.5 UAE Overactive Bladder Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Astellas Pharma
  7.1.1 Astellas Pharma Corporate Summary
  7.1.2 Astellas Pharma Business Overview
  7.1.3 Astellas Pharma Overactive Bladder Therapeutics Major Product Offerings
  7.1.4 Astellas Pharma Overactive Bladder Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Astellas Pharma Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan Overactive Bladder Therapeutics Major Product Offerings
  7.2.4 Allergan Overactive Bladder Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Allergan Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Overactive Bladder Therapeutics Major Product Offerings
  7.3.4 Pfizer Overactive Bladder Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Overactive Bladder Therapeutics Major Product Offerings
  7.4.4 Johnson & Johnson Overactive Bladder Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Teva (Activas)
  7.5.1 Teva (Activas) Corporate Summary
  7.5.2 Teva (Activas) Business Overview
  7.5.3 Teva (Activas) Overactive Bladder Therapeutics Major Product Offerings
  7.5.4 Teva (Activas) Overactive Bladder Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Teva (Activas) Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Overactive Bladder Therapeutics Market Opportunities & Trends in Global Market
Table 2. Overactive Bladder Therapeutics Market Drivers in Global Market
Table 3. Overactive Bladder Therapeutics Market Restraints in Global Market
Table 4. Key Players of Overactive Bladder Therapeutics in Global Market
Table 5. Top Overactive Bladder Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Overactive Bladder Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Overactive Bladder Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Overactive Bladder Therapeutics Product Type
Table 9. List of Global Tier 1 Overactive Bladder Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Overactive Bladder Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Overactive Bladder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Overactive Bladder Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Overactive Bladder Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Overactive Bladder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Overactive Bladder Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Overactive Bladder Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Overactive Bladder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Overactive Bladder Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Overactive Bladder Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Overactive Bladder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Overactive Bladder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Overactive Bladder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Overactive Bladder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Overactive Bladder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Astellas Pharma Corporate Summary
Table 31. Astellas Pharma Overactive Bladder Therapeutics Product Offerings
Table 32. Astellas Pharma Overactive Bladder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Overactive Bladder Therapeutics Product Offerings
Table 35. Allergan Overactive Bladder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Overactive Bladder Therapeutics Product Offerings
Table 38. Pfizer Overactive Bladder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Overactive Bladder Therapeutics Product Offerings
Table 41. Johnson & Johnson Overactive Bladder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Teva (Activas) Corporate Summary
Table 43. Teva (Activas) Overactive Bladder Therapeutics Product Offerings
Table 44. Teva (Activas) Overactive Bladder Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Overactive Bladder Therapeutics Segment by Type in 2021
Figure 2. Overactive Bladder Therapeutics Segment by Application in 2021
Figure 3. Global Overactive Bladder Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Overactive Bladder Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Overactive Bladder Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Overactive Bladder Therapeutics Revenue in 2021
Figure 8. By Type - Global Overactive Bladder Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Overactive Bladder Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Overactive Bladder Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Overactive Bladder Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Overactive Bladder Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Overactive Bladder Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Overactive Bladder Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Overactive Bladder Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Overactive Bladder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Astellas Pharma Overactive Bladder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Overactive Bladder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Overactive Bladder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Overactive Bladder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva (Activas) Overactive Bladder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)